Top Markets
Coin of the day
TMS Co., Ltd. TMS Co., Ltd.

TMS Co., Ltd.

4891
Classement en actions #27417
Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on... Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceuticals, quasi-drugs, drug substances, medical devices, and various medical commodities. The company's pipeline includes TMS-007, an SMTP congener demonstrating both prothrombolytic and anti-inflammatory/antioxidative activities, which has advanced through Phase 2a clinical trials for the treatment of acute ischemic stroke. Additionally, TMS-008, another SMTP congener with anti-inflammatory/antioxidative properties, is undergoing nonclinical development for addressing inflammatory complications like acute kidney injury and cancer cachexia. A third product candidate, TMS-009, is currently in preclinical development. TMS Co., Ltd. collaborates with Hokkaido University and Kanazawa University to assess the potential of its drug candidates, has a joint research agreement with Teikyo University to identify renal function biomarkers, and maintains a strategic alliance with Ji Xing Pharmaceuticals Limited.
Prix de l'action
$0.72420509
Capitalisation boursière
$33.00M
Changement (1 jour)
-0.89%
Changement (1 an)
-32.46%
Pays
JP
Échange TMS Co., Ltd. (4891)

Catégorie

Historique du prix de l'action pour TMS Co., Ltd. (4891)
Prix de clôture le plus élevé : $0.68 le 2026-08-01

Prix de clôture le plus bas : $5.48 le 2022-11-01
Historique du prix de l'action de TMS Co., Ltd. de 2022 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 5.13%
2025 -38.86%
2024 2.28%
2023 -76.40%
2022 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$759.01 6.64%
CH